Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study

BACKGROUND: Immune checkpoint inhibitors (ICIs) have achieved promising effects in patients with non-small cell lung cancer (NSCLC). However, not all patients with NSCLC benefit from immunotherapy. There is an urgent need to explore biomarkers that could predict the survival outcomes and therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Yi, Wang, Xinyan, Liu, Chenan, Jia, Junmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052648/
https://www.ncbi.nlm.nih.gov/pubmed/35484541
http://dx.doi.org/10.1186/s12890-022-01951-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052648/
https://www.ncbi.nlm.nih.gov/pubmed/35484541
http://dx.doi.org/10.1186/s12890-022-01951-x

Ejemplares similares